ARAMIS trial presented at #ISC23 dual antiplatelet therapy non-inferior to IV #alteplase in Chinese patient with mild, acute ischemic, stroke, presenting <4.5 hrs. Median NIHSS 2.
Mastodon is the best way to keep up with what's happening.
Follow anyone across the fediverse and see it all in chronological order. No algorithms, ads, or clickbait in sight.